• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

矛盾性高纤维蛋白溶解与严重先天性血友病中更严重的出血表型相关。

Paradoxical hyperfibrinolysis is associated with a more intensely haemorrhagic phenotype in severe congenital haemophilia.

作者信息

Grünewald M, Siegemund A, Grünewald A, Konegan A, Koksch M, Griesshammer M

机构信息

Department of Haematology, Haemostaseology Division, University of Ulm, Germany.

出版信息

Haemophilia. 2002 Nov;8(6):768-75. doi: 10.1046/j.1365-2516.2002.00686.x.

DOI:10.1046/j.1365-2516.2002.00686.x
PMID:12410645
Abstract

To elucidate potential causes for differing bleeding phenotypes of haemophilic patients of identical degree of coagulation factor deficiency, we investigated 21 male patients with severe haemophilia. Median annual coagulation factor demand and the extent of haemophilic arthropathy were used to discriminate between intensely and less intensely haemorrhagic phenotypes. Haemophiliacs with a median annual coagulation factor demand of 800 IU per kg bodyweight or more and with three or more joints affected by haemophilic arthropathy represented the intensely haemorrhagic phenotype group; all other patients comprised the less intense group. The discriminator values represent the respective medians of the overall group. The results of activated partial thromboplastin time, endogenous thrombin potential, pro- and anticoagulant factor analysis did not differ between the two groups. Median tissue-type plasminogen activator concentration (TPA) was elevated significantly in haemophiliacs with an intensely haemorrhagic phenotype, as was the activity of the thrombin-activatable fibrinolysis inhibitor. Median activity of the plasminogen activator inhibitor 1 (PAI 1) and the concentration of TPA-PAI 1 complexes were increased to approximately double those in nonsevere haemophiliacs. Coexistent congenital thrombophilia was found significantly more often in the less intensely haemorrhagic group. Thus, increased stimulation of the fibrinolytic system was associated with a more intensely haemorrhagic phenotype in our patients. We hypothesize that ineffective haemophilic haemostasis in response to trauma evokes a protracted stimulation of the entire haemostatic system, including costimulation of fibrinolysis. The absence of coexistent congenital thrombophilia predisposes to excess stimulation of fibrinolysis, which cannot be downregulated effectively due to the dysfunctional intrinsic pathway. The association of a more intensely haemorrhagic phenotype with a paradoxical hyperstimulation of the fibrinolytic system resembles a vicious circle, where bleeding seems to cause predisposition to more bleeding.

摘要

为阐明相同凝血因子缺乏程度的血友病患者出血表型不同的潜在原因,我们研究了21例重度血友病男性患者。采用每年凝血因子需求中位数和血友病性关节病的程度来区分出血频繁型和出血不那么频繁型表型。每年凝血因子需求中位数为每公斤体重800国际单位或更多且有三个或更多关节受血友病性关节病影响的血友病患者代表出血频繁型表型组;所有其他患者组成出血不那么频繁型组。区分值代表整个组各自的中位数。两组之间活化部分凝血活酶时间、内源性凝血酶潜力、促凝血和抗凝血因子分析结果无差异。出血频繁型表型的血友病患者组织型纤溶酶原激活剂浓度(TPA)中位数显著升高,凝血酶激活的纤溶抑制物活性也是如此。纤溶酶原激活剂抑制剂1(PAI 1)的活性中位数和TPA - PAI 1复合物的浓度增加到非重度血友病患者的约两倍。在出血不那么频繁型组中,共存先天性血栓形成倾向的情况明显更常见。因此,纤溶系统的刺激增加与我们患者中更频繁出血的表型相关。我们推测,创伤后血友病性止血无效会引发整个止血系统的长期刺激,包括纤溶的协同刺激。不存在共存先天性血栓形成倾向会导致纤溶过度刺激,由于内源性途径功能障碍,这种刺激无法有效下调。出血更频繁的表型与纤溶系统反常的过度刺激之间的关联类似于一个恶性循环,即出血似乎会导致更易出血。

相似文献

1
Paradoxical hyperfibrinolysis is associated with a more intensely haemorrhagic phenotype in severe congenital haemophilia.矛盾性高纤维蛋白溶解与严重先天性血友病中更严重的出血表型相关。
Haemophilia. 2002 Nov;8(6):768-75. doi: 10.1046/j.1365-2516.2002.00686.x.
2
Obesity in haemophilia patients: effect on bleeding frequency, clotting factor concentrate usage, and haemostatic and fibrinolytic parameters.血友病患者的肥胖问题:对出血频率、凝血因子浓缩物使用、止血和纤维蛋白溶解参数的影响。
Haemophilia. 2013 Sep;19(5):744-52. doi: 10.1111/hae.12182. Epub 2013 May 10.
3
The orthopaedic status of severe haemophiliacs in Spain.西班牙重度血友病患者的骨科状况。
Haemophilia. 2000 May;6(3):170-6. doi: 10.1046/j.1365-2516.2000.00397.x.
4
Is on-demand treatment effective in patients with severe haemophilia?按需治疗对重症血友病患者有效吗?
Haemophilia. 2012 Sep;18(5):738-42. doi: 10.1111/j.1365-2516.2012.02806.x. Epub 2012 Apr 27.
5
A novel therapeutic approach combining human plasma-derived Factors VIIa and X for haemophiliacs with inhibitors: evidence of a higher thrombin generation rate in vitro and more sustained haemostatic activity in vivo than obtained with Factor VIIa alone.一种将人血浆源性凝血因子VIIa和X联合用于有抑制剂的血友病患者的新型治疗方法:体外凝血酶生成率更高以及体内止血活性比单独使用凝血因子VIIa更持久的证据。
Vox Sang. 2003 Nov;85(4):290-9. doi: 10.1111/j.0042-9007.2003.00365.x.
6
Coagulation-dependent inhibition of fibrinolysis: role of carboxypeptidase-U and the premature lysis of clots from hemophilic plasma.凝血依赖性纤溶抑制:羧肽酶 - U的作用及血友病血浆中凝块的过早溶解
Blood. 1996 Nov 15;88(10):3815-23.
7
High dose factor VIIa improves clot structure and stability in a model of haemophilia B.高剂量凝血因子VIIa可改善乙型血友病模型中的血凝块结构和稳定性。
Br J Haematol. 2005 Dec;131(5):645-55. doi: 10.1111/j.1365-2141.2005.05820.x.
8
Presence of thrombophilia and levels of coagulation factors, coagulation inhibitors and TAFI do not affect global haemostasis or bleeding phenotype in patients with haemophilia A.
Thromb Res. 2019 Jan;173:1-3. doi: 10.1016/j.thromres.2018.11.008. Epub 2018 Nov 8.
9
Severe hemophilia with mild bleeding phenotype: molecular characterization and global coagulation profile.严重血友病伴轻度出血表型:分子特征和全球凝血谱。
J Thromb Haemost. 2010 Apr;8(4):737-43. doi: 10.1111/j.1538-7836.2010.03767.x. Epub 2009 Jan 21.
10
Haemarthrosis stimulates the synovial fibrinolytic system in haemophilic mice.血友病小鼠的关节积血可刺激滑膜纤维蛋白溶解系统。
Thromb Haemost. 2013 Jul;110(1):173-83. doi: 10.1160/TH13-01-0080. Epub 2013 May 16.

引用本文的文献

1
Plasmin generation analysis in patients with bleeding disorder of unknown cause.不明原因出血性疾病患者的纤溶酶原生成分析。
Blood Adv. 2024 Nov 12;8(21):5663-5673. doi: 10.1182/bloodadvances.2024012855.
2
Fibrinolysis and bleeding of unknown cause.纤维蛋白溶解与不明原因出血。
Res Pract Thromb Haemost. 2021 Apr 7;5(4):e12511. doi: 10.1002/rth2.12511. eCollection 2021 May.
3
Factor VIII prophylaxis effects outweigh other hemostasis contributors in predicting severe haemophilia A joint outcomes.VIII 因子预防治疗效果优于其他止血因素对预测重度血友病 A 关节预后的影响。
Haemophilia. 2019 Sep;25(5):867-875. doi: 10.1111/hae.13778. Epub 2019 May 21.
4
Mutation Spectrum and Genotype-Phenotype Analyses in a Pakistani Cohort With Hemophilia B.巴基斯坦B型血友病队列中的突变谱及基因型-表型分析
Clin Appl Thromb Hemost. 2018 Jul;24(5):741-748. doi: 10.1177/1076029617721011. Epub 2017 Jul 28.
5
Development and validation of a high throughput whole blood thrombolysis plate assay.高通量全血溶栓平板检测法的建立与验证。
Sci Rep. 2017 May 24;7(1):2346. doi: 10.1038/s41598-017-02498-2.
6
Fibrinolysis in patients with a mild-to-moderate bleeding tendency of unknown cause.病因不明的轻至中度出血倾向患者的纤维蛋白溶解。
Ann Hematol. 2017 Mar;96(3):489-495. doi: 10.1007/s00277-016-2893-6. Epub 2016 Dec 26.
7
Bleeding related to disturbed fibrinolysis.与纤维蛋白溶解紊乱相关的出血
Br J Haematol. 2016 Oct;175(1):12-23. doi: 10.1111/bjh.14255. Epub 2016 Aug 1.
8
Impact of Prothrombotic Risk Factors in a Cohort of Egyptian Hemophilia A Patients.埃及甲型血友病患者队列中血栓形成前危险因素的影响
Mol Diagn Ther. 2016 Apr;20(2):151-9. doi: 10.1007/s40291-015-0185-9.
9
Light chain of factor VIII is sufficient for accelerating cleavage of von Willebrand factor by ADAMTS13 metalloprotease.VIII 因子轻链足以加速 ADAMTS13 金属蛋白酶对血管性血友病因子的裂解。
J Biol Chem. 2012 Sep 21;287(39):32459-66. doi: 10.1074/jbc.M112.390690. Epub 2012 Aug 1.
10
Prophylaxis for adults with haemophilia: one size does not fit all.成人血友病的预防:一种方法并不适用于所有人。
Blood Transfus. 2012 Apr;10(2):169-73. doi: 10.2450/2012.0174-11.